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 Summary 
The current design for a tissue engineering (TE) skin substitute is that of a biodegradable 
scaffold through which fibroblasts can migrate and populate. This artificial ‘dermal layer’ 
needs to ‘take’ (adhere and integrate) to the wound, which is not always successful for 
the current artificial dermal analogues available (e.g. Integra®, Dermagraft® or 
TransCyte®). The high cost of these artificial dermal analogues also makes its application 
prohibitive both to surgeons and patients, and in certain cases, ethical issues may be 
involved too.  
 
Here, we propose a cost-effective composite consisting of a nanofibrous scaffold directly 
electrospun onto a TegadermTM wound dressing (TG-NF construct) for dermal wound 
healing. Cell culture is performed on both sides of the nanofibrous scaffold and tested for 
fibroblast integration and proliferation. It is hoped that these studies will result in a 
fibroblast populated three-dimensional dermal analogue that is feasible for layered 
applications to build up thickness of dermis prior to re-epithelialisation. The extent of 
injuries looked into largely refer to full or partial thickness injuries to the dermal tissues 
such as burn and chronic wounds. 
 
Results obtained in this study suggest that both the TG-NF construct and dual-sided 
fibroblasts populated nanofiber construct, achieved significant cell adhesion, growth and 
infiltration. This is a successful first step for the nanofiber construct in establishing itself 
as a suitable three-dimensional scaffold for autogenous fibroblasts population, and 
provides great potential in the treatment of dermal wounds through layered application. 
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 Chapter 1: Introduction 
The skin is the largest organ in the human body, covering the entire external surface and 
forming about 8% of the total body mass. The surface area of skin varies with height and 
weight.  For an individual 1.8m tall and weighing 90kg, it covers about 2.2m2. Thickness 
of skin varies from 1.5 – 4.0 mm, depending on skin maturity (ageing) and body region. 
 
The skin forms a self-renewing and self-repairing interface between the body and the 
environment. It provides an effective barrier against microbial invasion, and has 
properties that can protect against mechanical, chemical, osmotic, thermal and photo 
damage. It is capable of adsorption and excretion, and is selectively permeable to various 
chemical substances. [1] 
 
Skin also has good frictional properties, assisting locomotion and manipulation by its 
texture. Being elastic, it can be stretched and compressed within limits. The general state 
of health is commonly reflected by the appearance and condition of the skin, with the 
earliest signs of many systematic disorders being detected by inspection. Examination of 
skin is therefore important in diagnosing more than just skin diseases. [1, 2, 3] 
 
Skin is a relatively soft tissue and must be able to withstand large shear stresses. Trauma 
to the skin can be caused by many factors such as heat, chemicals, electricity, ultraviolet 
radiation or nuclear energy, and can result in several degrees of skin damage. The least 
damaging traumas tend to wound only the epithelium, which is the most superficial layer 
of skin. Wounded epithelium generally is healed by the body via re-epithelialization and 
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 does not require skin grafting. More serious trauma can lead to partial or complete 
damage to both dermal and subdermal tissues. [4] Wounds that extend partially through 
the dermis are capable of regeneration; the dermis provides a source of cells for its own 
reconstitution, while deep skin appendages such as hair follicles and sweat glands 
provide sources of epidermal cells to recreate the epidermis. Unfortunately, the body 
cannot heal deep dermal injuries adequately. In these cases, such as full thickness burns 
or deep ulcers, there are no remaining sources of cells for regeneration. [5] 
 
 




 According to worldwide statistics, an astonishing annual amount of US$5 billion is 
required for burn wound care. In the United Kingdom (UK), £600 million per year is 
expended for the treatment of chronic leg ulceration. In the United States (USA), US$9 
billion is spent per annum on wound care products. The average cost for wound healing 
ranges from US$27,000 for a pressure ulcer, to US$36,000 for a diabetic wound. In 
Singapore, an estimated annual expenditure of US$180 million goes into the treatment of 
chronic wounds. The UK and US statistics are now 10 years old, but with increasing 
cases of burn injuries arising from fire, accidents, terrorist attacks and an aging 
population (for chronic wounds), the numbers could now be much higher. These statistics 
show a potentially huge market for wound care products, and stress the need to lower the 
cost for dermal rehabilitation so that it can be made as easily available to the public as 
possible. 
 
1.1 Scope of Work 
The current design for a tissue engineering (TE) skin substitute is that of a biodegradable 
scaffold through which fibroblasts can migrate and populate. This artificial ‘dermal layer’ 
needs to ‘take’ (adhere and integrate) to the wound, which is not always successful for 
the current artificial dermal analogues available (e.g. Integra®, Dermagraft® or 
TransCyte®). The high cost of these artificial dermal analogues also makes its application 




 1.2 Objectives 
In this study, cell culture work is performed on both sides of individual PCL/gelatin 
nanofiber construct and also electrospun nanofibrous scaffold on TegadermTM wound 
dressing, which will be termed as the Tegaderm-Nanofiber (TG-NF) construct. A new 
technique is being put forth, where fibroblasts are cultured on both sides of a relatively 
thin construct of nanofibrous scaffold. This would increase the capacity of cells to be 
loaded into the scaffold structure and also engage cellular penetration from both sides of 
the scaffold instead of the usual convention of using one side of the nanofibrous scaffold. 
Our objectives in this study are to: 
 
• Investigate the feasibility of using the electrospun TG-NF construct as a cost-
effective scaffold for fibroblast integration and proliferation to establish a 
fibroblast populated dermal analogue,  
• Examine the possibility of dual-sided cellular growth on a nanofiber scaffold so as 
to establish a three dimensional fibroblast populated dermal analogue, and 
through which establish the feasibility of using the conceptualized autologous 
layered dermal reconstitution (ALDR) approach for layered applications of this 
TG-NF construct to build up thickness of dermis prior to re-epithelialisation 
 
The extent of injuries looked into largely refer to full or partial thickness injuries to the 
dermal tissues such as burns and chronic wounds. 
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 Chapter 2: Literature Review 
2.1 Nanofibrous Scaffold Fabrication Technique – Electrospinning 
Electrospinning has been known for over 60 years in the textile industry for 
manufacturing non-woven fiber fabrics. In recent years, there has been an increasing 
interest in exploiting this technology in the emerging area of nanobioengineering, which 
focuses mainly on using nanometer scale fibers for biomedical applications. This is 
especially so in fabrication of the nanofibrous scaffold for tissue engineering (TE). This 
technique produces non-woven membranes with individual fiber diameters ranging from 
50 to 800nm. The fibers form a large interconnected porous network that is ideal for 
drug, gene as well as cell delivery.  
 
In electrospinning, many factors can be manipulated in order to generate scaffolds of 
different geometries and with different structural properties. These include 
electrospinning parameters such as the electric field strength, the distance of electric 
field, the length and radius of the spinneret, the solution flow rate, and solution 
parameters such as concentration, viscosity, ionic strength and conductivity. [7] 
 
There is an increasing interest towards employing electrospinning for scaffold fabrication 
because the mechanical, biological and kinetic properties of the scaffold are easily 
manipulated by altering the polymer solution composition and processing parameters. 
Another advantage of using the electrospinning process is the ability to produce a 
nonwoven, nanometer scale fibrous structure, which has morphological and architectural 
features similar to that of the natural ECM, which comprises three dimensional network 
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 of nanoscaled fibrous protein structures embedded in glycosaminoglycan (GAG) 
hydrogel. [8] Additionally, the scaffold structure changes dynamically over time as the 
polymer nanofiber degrade, allowing the seeded cells to recreate and consolidate their 
own ECM. [9] In addition to the electrospinning of polymer materials, there are also 
approaches to electrospin natural biomaterials like collagen, fibrinogen and gelatin. [10 – 
14]  
 
Research in recent years has also established the widespread application of electrospun 
nanofibers in tissue engineering of bone [15], blood vessels [16], cartilage [17], 
peripheral nerve system [18], ligament [19], skeletal muscles [20], cardiac tissues [21] 
and skin [22].  
 
The nanofibrous scaffolds we present in this paper are electrospun from co-polymer poly 
(ε-caprolactone) (PCL)/gelatin (Type A) of 10% wt, with 2,2,2-trifluoroethanol (TFE) as 
the solvent. PCL is bioresorbable, biocompatible and has been studied as a wound 
dressing material as far back as the 1970s. Extensive research had been conducted on 
biocompatibility and efficacy, both in vitro and in vivo, resulting in FDA approval of a 
number of medical and drug delivery devices that are composed of PCL. At present, PCL 
is being regarded as a soft and hard tissue compatible bioresorbable material [23]. Gelatin 
is a natural biopolymer derived from collagen by controlled hydrolysis. Because of its 
many merits, such as its biological origin, biodegradability, biocompatibility, and 
commercial availability at relatively low cost, gelatin has been widely used in the 
pharmaceutical and medical fields. Preliminary studies have shown that the co-polymer 
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 of PCL/gelatin provides a compromised solution for overcoming the shortcomings of 
natural and synthetic polymers, resulting in a new biomaterial with good biocompatibility 
and improved mechanical, physical and chemical properties. [14] 
 
2.2 Basic Skin Anatomy 
Skin is one of the few organs of the body that are capable of regeneration. The two main 
layers of the skin include the epidermis, composed of stratified squamous epithelium, and 
the dermis, made up of dense connective tissue and fibroblasts in an extracellular matrix 
(ECM). The epidermis constantly proliferates and replaces itself while the dermis is rich 
in connective tissue that provides high tensile and elastic strength. (Figure 2.1) 
 
 
Figure 2.1: A pen drawing of complex structure of skin 
(M.H. Ross et al –History: A text and Altas, Williams and Wilkins, Baltimore, 1995) 
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The hypodermis comprises a looser connective tissue that lies beneath the dermis. The 
skin possesses sensory receptors, hair follicles for the production and growth of hair, and 
sweat glands which primarily regulate body temperature. [4]  
 
2.2.1 The Epidermis 
The skin is a physical barrier between the body and the external environment. The 
outermost layer of skin, the epidermis, must therefore be tough and impermeable to toxic 
substances or harmful organisms. It also controls the loss of water from the body to the 
relatively drier external environment. The epidermis is home to epithelial cells, 
keratinocytes as well as melanocytes (which gives skin its color and protection against 
ultraviolet rays). Proliferating cells in the basal layer of the epidermis anchor the 
epidermis to the dermis and replenish epithelial cells lost through normal exfoliation of 
the skin surface.  The most superficial keratinocytes in the epidermis form the dead 
outermost structure that, by its cornified nature, provides for mechanical barrier 
properties of the skin. [6] 
 
2.2.2 The Dermis 
The dermis underlies the epidermis. It provides physical strength and flexibility to skin as 
well as the matrix that supports the extensive vasculature, lymphatic system, and nerve 
bundles. The dermis is relatively accellular, composed predominantly of an ECM of 
interwoven collagen fibrils. Fibroblasts, the major cell type of the dermis, produce and 
maintain most of the ECM. Endothelial cells line the blood vessels and play a critical role 
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 in the skin immune system by controlling the extravasation of leukocytes. A network of 
nerve fibers extends throughout the dermis, serving a sensory role in the skin. These 
nerve fibers also secrete neuropeptides that influence immune and inflammatory 
responses in skin through their effect on endothelial cells, leukocytes and keratinocytes. 
[6] 
 
2.3 Skin or Cutaneous Wound Healing 
Since skin forms a protective barrier around the body, damage to the skin poses several 
immediate threats including rapid, severe dehydration and infection. [4] In burn wounds, 
these are life threatening injuries which require immediate care followed by careful 
evaluation and appropriate wound management. The severity of burns (Figure 2.2) will 






Figure 2.2: Skin layer and burn depth diagram 
(http://www.skinhealing.com) 
 
To prevent these, the standard treatment is an autograft, where a thin section of skin 
(including both the epidermis and partial thickness dermis) is removed from an 
unaffected part of the body and grafted onto the wound. The grafted skin will attach itself 
to the underlying tissue and effectively close the wound. A graft is successful when new 
blood vessels and tissues from the base integrate with the graft (take). 
 
However, skin grafts do not always take because of complications such as infection (most 
common cause of graft failure) or shearing (pressure causing the graft to detach from 
skin). When burns are widespread, there may be insufficient healthy skin available to 
graft onto the burn area. Healing by secondary intention over a prolonged period 
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 commonly result in poor scarring, leading to cosmetic and functional deformities. 
Restoration of skin loss using TE has overcome some of these problems.  
 
2.4 Synthetic Dermal Analogues 
The lack of sufficient donor sites on many burn and chronic wound patients and the 
generation of a donor defect by skin grafting have prompted the search for more widely 
available skin substitute. As a result, certain skin alternatives have been developed over 
the years and have obtained approval from the U.S Food and Drug Administration (FDA) 
for use in skin reconstructive procedures. 
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 2.4.1 Integra® Dermal Regeneration Template 
Integra® Dermal Regeneration Template (Integra Life Sciences, Plainsboro, NJ, USA) 
was approved by the FDA in 1996 for use in treatment of life threatening full or deep 
partial-thickness dermal injuries where sufficient autograft is not readily available at the 
time of excision or is undesirable due to the physiologic condition of the patient.  
 
Integra® is made of a bi-laminate membrane consisting of a bovine collagen-based 
dermal analogue and a temporary epidermal substitute layer of silicone. The dermal 
replacement layer of Integra® consists of a porous matrix of fibers of bovine type I 
collagen that is crosslinked with chondrotin-6-sulfate, and glycosaminoglycan (GAG) 
extracted from shark cartilage. The porous matrix is designed to act as a template for 
infiltration of the patient’s fibroblasts, macrophages, lymphocytes, and capillaries. The 
outer silicone layer of Integra serves as a temporary epidermis and allows for limited 
fluid flux, protection from microbial invasion, and prevention of wound dehydration.  
 
 




Integra® is placed on the excised wound for approximately 2 to 3 weeks, and during that 
time, the dermal component incorporates itself into the patient’s wound producing a 
neodermis. After the neodermis has been formed, the silicone layer is removed and a thin 
epidermal autograft of 0.005 inch may be applied with minimal donor site deformity. 
During the period between Integra® placement and epidermal autograft laying, the 
Integra® construct must be protected from mechanical dislodgement and observed daily 
for signs and symptoms of infection. A histologic evaluation of Integra® by Stern et al. 
[26] was conducted in 1990. 336 serial biopsies obtained from 131 patients in periods 
ranging from 7 days to 2 years after application of Integra®, showed restoration of an 
intact dermis with definitive closure of wound and minimal scarring. [24, 25]  
 
However, the disadvantage of Integra® application is the difficulty in obtaining an ultra-
thin epidermal autograft. Its thickness in dimension also causes difficulties for Integra® to 
‘take’ to the wound site. In addition, the small size of the Integra and high cost involved 




 2.4.2 Dermagraft® - Human Fibroblast-Derived Dermal Substitute 
Dermagraft® (Advanced Tissue Sciences, La Jolla, CA, USA) is a cryopreserved human 
allograft fibroblast-derived dermal substitute comprising of fibroblasts, ECM and a 
bioabsorbable scaffold.  
 
 
Figure 2.4: Dermagraft® – Human Fibroblast-Derived Dermal Substitute 
(http://www.advancedbiohealing.com) 
 
Human fibroblast cells are expanded and seeded onto a bioabsorbable scaffold under 
aseptic conditions. The cells are tested throughout the process for bacteria, viruses, fungi, 
and mycoplasma. The cells attach to the scaffold and multiply to fill the spaces within the 
scaffold during a 2-3 week period. They continue to divide and grow, secreting human 
growth factors, cytokines, ECM proteins and glycosaminoglycans. The end result is a 
cryopreserved three-dimensional human dermal substitute containing metabolically 
active living cells. [27] 
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A pilot study evaluated healing in 50 patients with diabetic foot ulcers treated with 
Dermagraft®. Ulcer healing was determined by the percentage of wound that achieved 
complete or 50% wound closure, time to closure, and volume and area measurements. 
Patients who received Dermagraft®, applied weekly for eight consecutive weeks, healed 
significantly faster than patients treated with traditional wound closure methods. In a 
larger controlled study of diabetic foot ulcers on 281 patients, it was also concluded that 
the Dermagraft® healing rate was higher compared to the control group. In addition, 
Dermagraft® appeared to delay ulcer recurrence in this study. [28] 
 
However, Dermagraft® cannot be used in ulcers that have signs of clinical infection or 
sinus tracts. Dermagraft® has also not been studied in wounds that extend to the tendon, 
muscle, joint capsules or bone. [27] 
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 2.4.3 TransCyte® – Human Fibroblast-Derived Temporary Skin Substitute 
TransCyte® (Advanced Tissue Sciences, La Jolla, CA, USA) consists of a polymer 
membrane and neonatal human fibroblast cells cultured under aseptic conditions in vitro 
on a porcine collagen coated nylon mesh. It acts as a temporary wound covering for 
surgically excised full-thickness and partial-thickness wounds, to protect the wound from 
environmental insults. In addition, the membrane is semi-permeable, thus allowing fluid 
and gaseous exchange. 
 
 
Figure 2.5: TransCyte® – Human Fibroblast Derived Temporary Skin Substitute 
(http://www.advancedbiohealing.com) 
 
Before incorporating the cells, this nylon mesh is coated with porcine dermal collagen 
and bonded to a polymer membrane (silicone). This membrane provides a transparent 
synthetic epidermis when the product is applied to the wound. As fibroblasts proliferate 
within the nylon mesh during the manufacturing process, they secrete human dermal 
-16- 
 collagen, matrix proteins and growth factors. Following freezing, no cellular metabolic 
activity remains. However, the tissue matrix and bound growth factors are left intact. The 
human fibroblast-derived temporary skin substitute provides a temporary protective 
barrier. It is transparent and allows direct visual monitoring of the wound bed. [29] 
 
Noordenbos et al. [30] conducted a randomized comparison study of silver sulfadiazine 
and TransCyte® using paired burn wound sites on 14 patients and a non-comparison 
evaluation on 18 patients. The investigation showed that burn wounds treated with 
TransCyte® healed more quickly than burn wounds treated with silver sulfadiazine (mean 
= 11.4 days to 90% epithelialization vs. 18.14 days). No infection occurred on the 32 
burn wounds treated with TransCyte®. In addition, the burn wound site evaluations 
completed at 3, 6 and 12 months revealed less hypertrophic scarring on TransCyte® 
treated wounds. [30] 
 
However, TransCyte® cannot be applied to patients who are sensitive to porcine dermal 
collagen. TransCyte® may also contain small traces of animal proteins due to exposure in 
the manufacturing process, and similarly in the pre-coating of the nylon mesh with 
porcine dermal collagen. The exposure of animal proteins to patients has been reduced by 
covering the nylon mesh with naturally secreted dermal protein. [29] Ethical issues pose a 
problem here too, as patients of certain religious faiths may not accept the porcine-
derived TransCyte® and the unknown source of human fibroblast cells used. 
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 TransCyte® is not suitable for prolonged application because it may result in 
immunological rejection by the patient. It has also not been established for application in 
burns of the head or hands, or in surgically excised full-thickness and deep partial-
thickness wounds prior to autografting. The nylon mesh used in TransCyte® is also not 
biodegradable. [24] In clinical trials, the only complication was that of fluid accumulation 
in the wound sites. 
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 2.5 TegadermTM Wound Dressing 
 
Figure 2.6: TegadermTM wound dressing, 3M (without acrylic adhesive) 
 
TegadermTM, a synthetic gas permeable membrane, is currently used as a common wound 
dressing (Figure 2.6). It is inexpensive, and earlier studies have shown it to be a reliable 
carrier for cultured epithelial allograft (CEA) in burns resurfacing. [32] It consists of a 
thin polyurethane membrane coated with a layer of an acrylic adhesive. The dressing 
functions such that it is selectively permeable to both water vapor and oxygen, and yet 
impermeable to microorganisms. Once placed in position, it provides an effective barrier 
to most forms of external contamination, and is still capable of maintaining a moist 
environment at the surface of the wound by reducing water vapor loss from the exposed 
tissue. Under such conditions in shallow wounds, scab formation is prevented and 
epidermal regeneration takes place at a faster rate as compared with regeneration in 
wounds treated with traditional dry dressings. 
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 The TegadermTM wound dressing can be used in the treatment of minor burns, pressure 
areas, donor sites, post-operative wounds, and a variety of minor injuries including 
abrasions and lacerations. It can also be used to cover and protect wounds, to maintain a 
moist environment for wound healing, as a secondary (cover) dressing, and as a 
protective cover over at-risk skin. It is not recommended that the material be applied over 
deep cavity wounds, third degree burns or wounds that show evidence of clinical 
infections. 
 
From previous works [34, 35], we have also concluded that TegadermTM is cheap, easily 
available, supports cell growth and can be used for TE of skin. 
 
In this current study, cell culture work is performed on both sides of individual 
PCL/gelatin nanofiber construct and also electrospun nanofiberous scaffold on 
TegadermTM wound dressing, which will be termed as the Tegaderm-Nanofiber (TG-NF) 
construct. A new technique is being put forth, where fibroblasts are cultured on both sides 
of a relatively thin construct of nanofibrous scaffold. This would increase the capacity of 
cells to be loaded into the scaffold structure and also engage cellular penetration from 
both sides of the scaffold instead of the usual convention of using one side of the 
nanofibrous scaffold. For the TG-NF construct, the nanofibrous scaffold allows fibroblast 
cells to have a structure for population and growth with the TegadermTM dressing taking 
on the role of a synthetic epidermis, providing a protective barrier from external 
infections and maintaining a moist environment for dermal regeneration to take place. 
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 Chapter 3: Materials and Experimental Methodology 
3.1 Materials 
The polymers gelatin Type A (approx. 300 Bloom, Sigma, St. Louis, MO) from porcine 
skin in powder form and poly (ε-caprolactone) (PCL) with an average molecular weight 
of 80,000 (80 kDa), were used together with 2,2,2-trifluoroethanol (TFE) as solvent. The 
polymers and solvent were of analytical grade and used as received from Fisher 
Chemicals (Leicestershire, UK). Human dermal fibroblast (HDF) cells were obtained 
from an 8-month-old Chinese infant (CellResearch Corporation). All culture media and 
reagents were purchased from Research Biolabs (Sigma, St Louis, MO, USA). CellTiter 
96® AQueous one solution reagent was purchased from Promega (Madison, WI, USA). 
CMFDA fluorescent CellTracker probe was purchased from Molecular Probe (Eugene, 
OR, USA). 
 
3.2 Fabrication of PCL/gelatin scaffolds and TG-NF constructs 
A polymer blend solution of PCL/gelatin/TFE was prepared by mixing 10%w/v 
PCL/TFE and 10%w/v gelatin/TFE in 50:50 portions under gentle stirring to be used for 
the nanofibrous scaffold preparation. The nanofibrous scaffolds were subsequently 
electrospun using the electrospinning setup (Fig. 3.1). The TG-NF constructs were 
fabricated in similar fashion, but with the PCL/gelatin nanofibers being electrospun 
directly onto the TegadermTM wound dressing (Fig. 3.2). 
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  Tygon Tubing Syringe pump 
Syringe needle forms 
the spinneret of  the 
electrospinning setup 
Electrospinning of nanofibers 
 
Figure 3.1: Schematic diagram for electrospinning apparatus 
 
 
Figure 3.2: Tegaderm-Nanofiber (TG-NF) construct 
 
 
High voltage power supply Ground collector with 




 For the process of electrospinning, the polymer solution was placed in a 10ml plastic 
syringe fitted with a needle with tip diameter of 0.4mm. Electrospinning voltage was 
applied between the needle and the grounded collector at 10.5kV using a high voltage 
power supply (Gamma High-Voltage Research, FL, USA). Above a critical voltage, a 
polymer jet was ejected from the needle tip towards a grounded collector which was laid 
with either a TegadermTM wound dressing or aluminium foil.  The needle is located at a 
distance of 150mm from the gound collector. A syringe pump was used to feed the 
polymer solution to the needle tip at a feed rate of 0.7 ml/h. The constructs were dried 
under vacuum at room temperature.  
 
The thickness of the PCL/gelatin nanofibrous scaffolds was measured with the aid of a 
micrometer (Mitutoyo, Japan) and its apparent density, bulk density and porosity were 
estimated through the following equation [34]: 
 




ggelatinofMassgPCLofMass +=      … (3.1) 
 





×=      … (3.2) 
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cmgdensityapparentScaffold     … (3.3) 
 
3.3 Characterization of PCL/gelatin scaffolds and TG-NF constructs 
For characterization, the constructs were sputter coated with gold (JEOL, JFC-1200 Fine 
Coater, Japan). Surface morphology of the constructs was obtained using the Field 
Emission Scanning Electron Microscopy (JEOL, JSM-5600, Japan) at an accelerating 
voltage of 15 kV. All the prepared constructs were sterilized with ultraviolet (UV) light 
for 2 hours and prewet with 70% ethanol for up to 24 hours. This wetting process is 
important for hydrophobic polymers like PCL, as it aids in overcoming the hindered entry 
of water into the air-filled pores within the scaffolds [16]. Subsequently, the scaffolds and 
constructs were soaked in Dulbecco’s modified Eagle’s medium (DMEM; Sigma, St 
Louis, MO USA) with 10% fetal bovine serum (FBS; Sigma, St Louis, MO, USA) 
overnight to ensure protein adsorption which would facilitate cell attachment.   
 
3.4 In vitro culture of HDFs 
HDFs were plated as a monolayer and cultured to confluence in DMEM containing 10% 
FBS and 1% antibiotic solution (penicillin-streptomycin; Sigma, St Louis, MO, USA). 
Media was replaced every three days and the cultures were maintained in a humidified 
incubator at 37oC with 5% CO2. Once the HDFs reached 70% confluence, they were 
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 trypsinized and passaged at 1:3 ratios. Second to fifth passages of HDFs were used in this 
study. 
3.5 HDFs seeding onto PCL/gelatin scaffolds and TG-NF constructs 
HDFs were detached with 1X trypsin and the number of cells was counted with a 
hemocytometer. The resulting cells in suspension were then seeded onto the TG-NF 
constructs and incubated for 7 days, with PCL/gelatin nanofiber scaffolds as control. For 
a separate set of study, HDF cells were also seeded separately onto the PCL/gelatin 
nanofiber scaffolds as well as tissue culture plastic (TCPS) of the 24-well plates, which 
was to serve as a negative control. The HDF cells were first seeded on the top surface of 
the PCL/gelatin nanofiber scaffold and incubated for 7 days. The scaffolds were then 
flipped over, and incubated for another 7 days with new HDF cells seeded again on the 
bottom surface. Culture media used was changed every 3 days.  
 
3.6 Field emission scanning electron microscopy (FESEM)  
FESEM micrographs of the TG-NF constructs and PCL/gelatin nanofiber scaffolds were 
taken when HDFs attached and proliferated on the different substrates 3, 5 and 7 days 
after seeding. Briefly, the substrates were harvested, washed with 1X phosphate buffered 
saline (PBS) solution and then fixed with 2.5% glutaraldehyde. Following three rinses 
with distilled water, the samples were dehydrated through a series of graded ethanol 
solutions, and then air-dried overnight. Dry constructs were sputter coated with gold and 
observed under the FESEM at an accelerating voltage of 5.0 kV. 
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 3.7 HDFs morphology, viability, attachment and count studies 
Cell morphology was studied using the FESEM and Laser Scanning Confocal 
Microscopy (LSCM, Leica, Germany). HDFs were seeded at a density of 10,000 cells per 
well onto the PCL/gelatin scaffolds and TG-NF constructs. Such low densities were used 
for proliferation studies because there would be more available areas for cells to 
proliferate, and also to avoid reaching confluence prematurely. For LSCM observations, 
the seeded HDFs were stained with green fluorescence probe 5-chloromethyl fluoroscien 
diacetate (CMFDA) and observed under the LSCM (excitation 492nm, emission 517nm). 
Cell viability and attachments were determined by MTS assay. The number of attached 
cells was also determined by cell counting. 
 
3.8 MTS assay 
To study cell proliferation on the substrates, viable cells were determined by using the 
colorimetric MTS assay (CellTiter 96® AQueous Assay, Madison, WI, USA). The 
mechanism behind this assay is that metabolically active cells will react with the 
tetrazolium salt in the MTS reagent to produce a soluble formazan dye that can be 
absorbed at 492nm.  
 
The substrates were rinsed with PBS, followed by incubation with 20% MTS reagent in 
serum-free culture medium for 3 hours. Thereafter, aliquots were pipetted into a 96-well 
plate. The 96-well plate was then placed into a spectrophotometric plate reader 
(FLUOstar OPTIMA, BMG Lab technologies, Germany) and the absorbance at 492nm of 
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 the content of each well was measured. These absorbance values are subsequently used to 
plot the growth of HDFs and gauge its concentration. However, they do not represent the 
number of HDFs present. Such absorbance values are also known as optical densities. 
 
3.9 HDFs counting 
In order to count the number of viable cells attached to the PCL/gelatin scaffolds and TG-
NF constructs, the substrates were harvested, washed with PBS to remove non-adherent 
cells, and then incubated in 0.5 ml of 1x trypsin at 37oC for 5 min. The trypsinization 
process was stopped by adding 0.5 ml of DMEM to each sample. The cell numbers were 
then counted using a hematocytometer and microscope. 
 
3.10 Dual side HDF growth on PCL/gelatin scaffold 
 
Day 7: HDF seeded onto nanofiber 
scaffold bottom side 
Day 1: HDF seeded onto nanofiber 
scaffold top side 
 
Figure 3.3: Schematic of proposed dual side HDF growth on a nanofiber scaffold 
 
HDF seeded scaffold 
flipped over at Day 7 
HDF to be seeded onto top 
side of nanofiber scaffold  
HDF to be seeded onto top 
side of nanofiber scaffold  
HDF proliferation and infiltration HDF proliferation and infiltration 
Single side fibroblast seeded  Dual side fibroblast seeded 
PCL/Gelatin nanofiber scaffold PCL/Gelatin nanofiber scaffold
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 In this approach, conventional methods of cell seeding and culture works were performed 
on one side of the nanofiber construct and allowed for cell proliferation and penetration 
for up to 7 days. Subsequently, the construct was flipped over and the entire process was 
repeated for another span of 7 days. Cell viability assays were conducted through the 
entire 14-day span at regular time interval to ensure stability and consistency in cell 
proliferation. FESEM and LSCM micrographs were also taken to observe HDF 
population on each side of the scaffold.
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 Chapter 4: Results and Discussion 
4.1 Morphology of electrospun PCL/gelatin nanofibrous scaffold 
Morphological image of the PCL/gelatin nanofiber, which was similarly electrospun onto 
TegadermTM wound dressing to form the TG-NF construct, were taken using the FESEM 
and shown in Figure 4.1. The micrograph image depicted randomly interconnected 
structures and seemingly smooth morphology of the electrospun PCL/gelatin nanofiber. 
The diameter of the nanofiber estimated to be in the range of 300 – 600 nm (90% 
nanofibers) with a mean diameter of 470 ± 120 nm by using the image analysis software 
(ImageJ, National Institutes of Health, USA). The PCL/gelatin nanofiber mat with a 
thickness of around 28 µm was obtained through 2.5 hours of electrospinning. Knowing 
the estimated bulk density of the PCL/gelatin (1.2–1.3 g/cm3), along with the calculated 
value of its apparent density, the porosity of the PCL/gelatin naofibrous scaffold could 
subsequently be calculated. These results are summarized in Table 1.  
 
 
Figure 4.1: FESEM micrographs of PCL/gelatin nanofibrous scaffold  
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 Porosity is viewed as a crucial parameter for tissue engineered scaffolds. Such 
y be made 
inue 
 







 is not easy to create well defined pore sizes through the electrospinning technique 
nanofibrous scaffolds which would be used for skin reconstitution should largel
porous. The porous nature of the scaffolds would then be beneficial for cellular 
infiltration and proliferation. On the other hand, the porous structure should cont
aiding in hemostasis, as well as ensuring sufficient gaseous and nutrients exchange for
wound healing.  
 
A
penetration should generally be within the range of 60% to 90%. This could eas
achieved via phase separation and solid free-form fabrication techniques. The porosity
the electrospun PCL/gelatin nanofibrous scaffolds in this study is estimated to be around 
60-70%, comparable to the techniques mentioned previously. The pores generated within 
the scaffold structure for cellular in-growth are formed by nanofibers lying upon each 
other which are different from isotropic pores made by using particles or bubbles when
the scaffold is solidified. [10] Previous studies on PCL/gelatin nanofibers have also 
shown that the gelatin component of the co-polymer is gradually dissolved during ce
culture, thus creating more spaces for cell migration. Similarly, the good elongation and
deformation properties of gelatin provides easier opening of spaces for cell penetration to
deeper level of the scaffold. [16] 
 
It
because of the randomly deposited fibers. However, the overall network architecture 
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 structure fabricated best mimic the natural ECM and this provides an advantage in its 
application as tissue engineered scaffolds. [10] 
 













470 ± 120 28 ± 6 1.21 ± 0.13 0.43 ± 0.06 62 – 75 
 
Data are representative of three independent experiment and all data recorded as mean 
values ± SD (n=3) 
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 4.2 Cell proliferation studies on TG-NF construct and PCL/gelatin 
scaffold 
HDF proliferation on the TG-NF constructs was studied at Days 1, 3, 5, and 7, with 
results shown in Figures 4.2 and 4.3. The PCL/gelatin scaffolds were used as control. 
Both the optical density and number of cells were noted to have increased significantly 
through the 7-day span, demonstrating that cell proliferation occurred successfully on 























Figure 4.2: HDFs proliferation results (Cell viability) 
Data are representative of three independent experiment and all data points plotted as 
mean values ± SD (n=3) 
 
-32- 
 In Figure 4.2, it was observed that optical density of HDFs on both substrates kept 
increasing. The HDFs would continue to proliferate till confluence by which there would 
be no further available surface area on the constructs for further proliferation. This result 
is substantiated by the observations made in Figure 4.3, where cell counts were also noted 



















Figure 4.3: HDFs proliferation results (Cell counting) 
Data are representative of three independent experiment and all data points plotted as 
mean values ± SD (n=3) 
 
At every time point, the numbers of cells present on the PCL/gelatin scaffold and TG-NF 
construct were comparable, demonstrating that cell growth were comparable on both 
types of substrates. The presence of the TegadermTM wound dressing in combination with 
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 the nanofiber scaffold does not have any negative influence on cell proliferation. Instead, 
it does not hinder cell growth and is able to function in its role as a synthetic epidermis 
for protection of wound site. Therefore, it can be concluded that the TG-NF construct is a 
suitable non-toxic substrate for cell growth and proliferation.  
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 4.3 Cellular morphology on TG-NF construct and PCL/gelatin scaffold 
 
(a) Day 3 – (b) Day 3 – TG-
(c) Day 5 – (d) Day 5 – TG-
(e) Day 7 – (f) Day 7 – TG-
 
Figure 4.4: FESEM images of HDFs on PCL/gelatin scaffolds and TG-NF constructs:  
(a) Day 3 – PCL/gelatin scaffold (1000x). (b) Day 3 – TG-NF construct (1000x). (c) Day 
5 – PCL/gelatin scaffold (500x). (d) Day 5 – TG-NF construct (500x). (e) Day 7 – 
PCL/gelatin scaffold (1000x). (f) Day 7 – TG-NF construct (1000x). 
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l morphology on the PCL/gelatin scaffolds and TG-constructs was studied by FESE
 5 and 7, with the results shown in Figure 4.4. Confluency of HDFs on
Cel M 
at Days 3,  the TG-
F constructs and PCL/gelatin nanofiber scaffolds were then estimated via visual N
observation and inspection. It was observed that at Day 3 (Figures 4.4a and 4.4b), HDFs 
only reached approximately 20% confluence. This was due to the low HDF seeding 
density used in this study in order to observe proliferation over a 7-day span. The cells 
were seen to be characteristically elongated and stretched across the nanofibrous 
substrates during the course of proliferation. Subsequently at Day 5 (Figures 4.4c and 
4.4d), it was observed that the HDFs had increased in numbers and reached about 50% 
confluence on both substrates. HDF proliferation and growth continued progressively and 
by Day 7 (Figures 4.4e and 4.4f), the cells had already increased significantly in numbers, 
reaching a confluency of about 70%. Both the PCL/gelatin scaffold and TG-NF construct 
were almost completely proliferated with HDFs. From the FESEM micrographs taken, it 
was established that there was successful HDF proliferation and adherence on both 
substrates. Comparing the FESEM micrographs taken for both the PCL/gelatin scaffolds 
and TG-NF constructs at each time point, it was observed that the density of HDFs on 
both substrates was always comparable and that the visible confluence of the cells 
reached was almost equivalent. From this experimental data, it can be seen that the TG-
NF construct can be considered a suitable host substrate for fibroblast population, with 




 With the aim of establishing the nanofiber construct as an autogenous fibroblast 
populated three-dimensional scaffold for wound healing purposes, there needs to be cell 
igration into the scaffold structure and not just on the substrate surface.  Such m
maximized cellular in-growth would result in close biomimicry of the natural 
extracellular matrix (ECM). From the FESEM micrograph shown in Figure 4.5, it was 
observed that there was not much significant fibroblast infiltration within the scaffold 
structure. Noticeably, there was slight penetration within the top most layers of 
nanofibers, but not in-depth enough to be justified as a well populated three dimensional 
stereo-structure. The main reason being that the pores formed in the nanofiber scaffolds 
were still relatively small in comparison with the fibroblast cells, which are of sizes 10-
100 micron. To overcome this problem, methods such as fiber leaching was proposed 
previously [37] to create micropores to encourage cell infiltration. However, in our study 
here, we propose a new approach to resolve this problem. Fibroblasts are cultured on both 
sides of a relatively thin construct of nanofibrous scaffold, such that the cells can 
proliferate, populate and penetrate from both sides (Figure 3.3). This would increase the 
cell loading capacity as compared to that of the usual loading cells on only one-side of 
the scaffold.  
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Figure 4.5: FESEM image showing slight penetration of HDF within top most layers of 
nanofibers (Magnification 5000x)  
 
4.4 Dual side HDF growth on PCL/gelatin scaffold 
In this experiment on dual side HDF growth on PCL/gelatin scaffold, FESEM and LSCM 
micrographs were taken to observe HDF population on each side of the scaffold. HDFs 
were seeded onto one side of the scaffold and allowed for cell proliferation for up to 7 
days. This side of the scaffold is termed “Top side”. Subsequently, the scaffold was 
flipped over and HDFs were seeded again. This opposite side of the scaffold is termed 
“Bottom side”. Thus, by the end of the 14-days span, the top side of the scaffold would 
have undergone 14 days of cell culture, compared with the bottom side which had 
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 undergone 7 days. The viability assay results, FESEM and LSCM micrographs are shown 




















PCL/Gelatin Scaffold (Dual side seeded)
(b) HDF seeding on both sides
of PCL/Gelatin scaffold 
Scaffolds flipped over at Day 7 
(a) HDF seeding on one side of 
PCL/Gelatin scaffold 
 
Figure 4.6: HDF proliferation results (Cell viability)  
– (a) One side of nanofiber scaffold, and (b) Both side of nanofiber scaffold. 
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 (a) (b) 
(c) (d) 
 
Figure 4.7: FESEM and LSCM images of HDF population on PCL/gelatin scaffold  
– Left: Top side; Right: Bottom side. 
 
Results from the viability studies (Figure 4.6) show that the fibroblasts grow and 
proliferate well on both sides of the nanofiber scaffold. Optical density of the cells 
increased through the first 7 days span (Figure 4.6a). This result was similar to the ones 
obtained in the first part of the studies on TG-NF where HDF seeded PCL/gelatin 
scaffold was used as a control. Subsequently, the viability studies were conducted again 
on the opposite side. This time, the optical density was appreciably higher at the regular 
time points, as compared with the control PCL/gelatin scaffold with HDF seeded on one 
side only (Figure 4.6b). This happens because cell proliferation had now continuously 
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 occurred on both sides of the scaffold and the flipping over of scaffold did not affect 
cellular activities. These results were justified from micrographs taken using the FESEM 
and LSCM as shown in Figure 4.7. Significantly at Day 14, it was observed from the 
FESEM micrograph that one side of the scaffold was very confluent with HDF 
population (Top side) while the other side (Bottom side) was distinctly 70% confluent. In 
this case, the former is the side which was seeded with HDF earlier and the latter being 
the side which had HDF seeded at a later phase. These separate images also showed that 
the fibroblast cells proliferated as usual on both sides of the scaffold without any 
compromise. Given that such a phenomenon happens on both sides of the nanofibrous 
scaffold and coupled with the thinness of the construct, a split-thinness fibroblast 
populated scaffold will now be possibly feasible.  
 
-41- 
 Chapter 5: Conclusions 
In this study, the objective of investigating the feasibility of the TG-NF construct as an 
effective TE scaffold for fibroblast integration and proliferation to establish a fibroblast 
populated dermal analogue was achieved. Results from experiments confirmed that HDF 
cells can grow and proliferate well on the TG-NF construct; in fact as well as on a usual 
nanofiber scaffold, which has been gaining recognition in recent researches as being a 
suitable biodegradable scaffold for skin substitutes. There is thus the added incentive of 
electrospinning nanofibers onto TegadermTM wound dressing, which acts as a synthetic 
epidermis to protect both the wound and the fibroblast-populated nanofiber lattice from 
contamination and does not compromise HDF proliferation.  
 
In line with developing a three dimensional scaffold construct for HDF infiltration, the 
fibroblast cells were successfully cultivated on both sides of a thin PCL/gelatin nanofiber 
scaffold. This allowed cell growth and penetration from both sides of the scaffold, thus 
maximizing cell loading and growth into the scaffold structure which mimics the natural 
ECM.  
 
The data obtained from these experiments are an important first step in the development 
of nanofibrous scaffold as a suitable dermal analogue to assist in skin cover and 
regeneration. Ultimately, the nanofibrous scaffold is a thin one, and may be insufficient 
to replace the lost dermis in terms of thickness. Clinical studies downstream will 
investigate the feasibility of adding successive layers of the dual-sided fibroblast seeded 
scaffolds to reconstitute full dermal thickness (Autologous Layered Dermal 
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 Reconstitution: ALDR) [46] before final application of keratinocytes, either as a thin split 
thickness skin graft or as unpolarized keratinocytes sprayed on in combination with fibrin 
glue, to reconstitute the epidermis and achieve full skin reconstitution. 
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 Chapter 6: Recommendations 
Through the course of this study, certain limitations and difficulties were encountered. 
Various means of improvement were also identified for future studies into this area: 
 
1. Aligned or core-shell nanofibers – Using these approaches would result in better 
control over the porosity, pore sizes and structural properties of the scaffold. The 
resultant topography would better promote HDF adhesion, proliferation and 
integration [18]. 
2. Use of composite nanofibers – Nanofibers could be coated with suitable growth 
factors and proteins to promote cell adhesion, proliferation and growth on and within 
the scaffold.  
3. Autologous Layered Dermal Reconstitution (ALDR) – Further clinical investigations 
will be made into the layered application of the TG-NF construct to build up the 
injured dermis prior to re-epithelialisation using split-thickness skin graft.  
4. Composite cultured skin – By applying the concept of dual side cell seeding on 
nanofibrous scaffold, a composite skin structure made up of layered keratinocytes-
scaffold-fibroblast could be developed. 
5. Variance in cell types – Since HDF has already been used in this study for dermal 
regeneration, a similar approach could be made applicable using other cell types e.g. 
osteoblasts and SMCs. If proven successful, this approach could be expanded towards 
applications in TE bone or muscle regeneration. 
 
-44- 
 6.1 Autologous Layered Dermal Reconstitution (ALDR) 
 
Step 1: Chronic/burn wound on human skin 
 
Figure 6.1: Schematic of Autologous Layered Dermal Reconstitution (ALDR) 
 
In the process of wound healing and dermal reconstitution, it is important that the 
replacement analogue has a good “take” onto the wound site so as to facilitate and 
enhance re-epithelization. However, current artificial dermal analogues have significant 
thickness such that the “take” rate is relatively lower. In line with the thinness of the TG-
NF constructs and three-dimensional fibroblast incorporated scaffold, a new technique of 
approaching dermal wound healing (ALDR) is proposed so as to achieve better “take” 
onto wound sites and also obtain better wound healing results [46]. In the proposed 
schematic illustration shown in Figure 6.1, layered applications of the constructs are 
* Layered application until 70-80% of original dermis thickness is 
reconstituted 
Step 4: Second layer application of TG-NF 
construct (HDF seeded)  with damaged dermal layer 
Step 2: First layer application of TG-NF 
construct (HDF seeded) 
Step 5: Autologous skin graft or sprayed autologous 
keratinocytes to reconstitute dermis 
Step 3: Peeling off Tegaderm wound dressing 
(After a few days) 
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 continued, with subsequent removal of the TegadermTM wound dressing, until at least 70-
80% of the original dermal layer has been reconstituted. A split thinness autograft or 
sprayed kertinocytes can then be applied to reconstitute the remaining epidermal layer. 
The ALDR approach to dermal wound healing is novel and unique and further clinical 
testing is required to provide actual results [46] so as to explore its feasibility.  
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 Appendix A: Morphological images of cell growth 
Day 3: PCL scaffold (left) and TG-NF construct (right) 
Day 5: PCL scaffold (left) and TG-NF construct (right) 
Day 7: PCL scaffold (left) and TG-NF construct (right)  
-VII- 
